Related Experiment Video
Updated: May 2, 2026
07:58
Cell-Free DNA Integrity Analysis in Urine Samples
Published on: January 5, 2017
14.2K
Evaluation of single-nucleotide variants in bladder cancer using prediction algorithms
June Möller1,2, Lancelot Seillier1,2, Axel Fürstberger3
1Institute of Pathology, University Hospital RWTH Aachen, Pauwelsstraße 30, 52074, Aachen, Germany.
Pathologie (Heidelberg, Germany)
|December 3, 2025
Summary
Combining genetic prediction tools improves bladder and urinary tract cancer analysis. Optimal tool selection depends on cancer type and gene function for better diagnostic accuracy.
Area of Science:
- Genomics
- Bioinformatics
- Cancer Research
Background:
- Bladder and urinary tract cancers have poor survival rates, necessitating new therapeutic approaches.
- Omics advancements offer genetic analysis tools, but their efficacy varies by tumor type.
Purpose of the Study:
- To evaluate the performance of genetic prediction tools in bladder and urinary tract cancers.
- To compare different prediction tool combinations and their accuracy.
Main Methods:
- Utilized variant data from ClinVar and cBioPortal for bladder cancer, PanCancer, and benign variants.
- Assessed 16 prediction algorithms individually and in combinations of two or three.
- Compared oncogenes and tumor suppressors, analyzing an additional PanCancer dataset.
Main Results:
- Prediction tool performance varied significantly across different datasets.
- Combinations of three tools yielded the highest sensitivity (100%) and specificity (97.45%).
- Observed distinct performance differences based on cancer entity and gene type.
Conclusions:
- Combining multiple prediction tools enhances the accuracy of genetic analysis in cancer research.
- The choice of prediction tools should be tailored to the specific cancer entity, gene function, and research objectives.
